Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001192621-25-000002
Filing Date
2025-01-13
Accepted
2025-01-13 16:07:18
Documents
1
Period of Report
2025-01-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1736802432.html 4  
1 FORM 4 wk-form4_1736802432.xml 4 3384
  Complete submission text file 0001192621-25-000002.txt   5158
Mailing Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920 908-229-2590
LISATA THERAPEUTICS, INC. (Issuer) CIK: 0000320017 (see all company filings)

EIN.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CAMBREX CORP ONE MEADOWLANDS PLZ EAST RUTHERFORD NJ 07073
Business Address
KLOSK STEVEN M (Reporting) CIK: 0001192621 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33650 | Film No.: 25526436